Company Description

Rebase Biotech's multidisciplinary team of scientists and researchers are committed to pushing the boundaries of knowledge and developing groundbreaking solutions that provide selective delivery of cytotoxic agents to tumor site without the use of antibodies and achieving synthetic lethality in BRCA mutated cancers through new mechanisms for the benefit of patients with difficult to treat cancers.